Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

61.05
Delayed Data
As of May 22
 -0.37 / -0.60%
Today’s Change
47.36
Today|||52-Week Range
68.75
+6.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line751.8M841.2M696.6M411.6M
 
 
 
 
 
Depreciation377.3M349.7M370.3M310.6M
 
 
 
 
 
Total Other Cash Flow86.9M176.7M185.4M74.2M
 
 
 
 
 
Funds From Operations1.2B1.3B1.2B620.2M
 
 
 
 
 
Funds From/For Other Operating Expenses89.2M-124.6M-506.8M-635.0M
 
 
 
 
 
Net Cash Flow - Operating Activities1.1B1.4B1.8B1.3B
 
 
 
 
 
 
InvestingCapital Expenditures-193.6M-205.9M-300.7M-171.5M
 
 
 
 
 
Fixed Asset Disposal125.5M13.0M39.2M76.0M
 
 
 
 
 
Net Assets From Acquisitions 621.8K-197.5M-404.6K0.00
 
 
 
 
Other Investing - Uses-120.5M-128.9M-86.3M-109.4M
 
 
 
 
 
Other Investing - Sources0.000.000.001.9M
 
 
Net Cash Flow Investing-187.9M-519.3M-348.2M-203.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-619.2M-94.0M-13.4M15.8M
 
 
 
 
 
Long Term Borrowings0.000.000.002.0B
 
 
Long Term Debt Reduction-15.3M-----1.4B
 
 
 
Net Proceeds Stock Sale113.1M77.0M224.3M153.9M
 
 
 
 
 
Common Preferred Redeemed0.000.00-500.0M-407.0M
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-301.8M-285.4M-273.0M-268.8M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing4.0M802.9M-806.1M44.5M
 
 
 
 
 
Net Cash Flow - Financing-827.2M-308.2M-595.0M86.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.1M-42.8M-59.1M-53.8M
 
 
 
 
 
 
Net Change In Cash48.1M567.4M812.5M1.1B
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account